Evoke Wealth’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-309
| Closed | -$222K | – | 397 |
|
2023
Q2 | $222K | Buy |
+309
| New | +$222K | 0.01% | 326 |
|
2022
Q4 | – | Sell |
-77
| Closed | -$53K | – | 962 |
|
2022
Q3 | $53K | Sell |
77
-2
| -3% | -$1.38K | ﹤0.01% | 510 |
|
2022
Q2 | $47K | Buy |
79
+8
| +11% | +$4.76K | ﹤0.01% | 525 |
|
2022
Q1 | $50K | Buy |
71
+14
| +25% | +$9.86K | ﹤0.01% | 525 |
|
2021
Q4 | $36K | Sell |
57
-1
| -2% | -$632 | ﹤0.01% | 578 |
|
2021
Q3 | $35K | Buy |
58
+47
| +427% | +$28.4K | ﹤0.01% | 554 |
|
2021
Q2 | $6K | Hold |
11
| – | – | ﹤0.01% | 842 |
|
2021
Q1 | $5K | Buy |
11
+4
| +57% | +$1.82K | ﹤0.01% | 861 |
|
2020
Q4 | $3K | Sell |
7
-3
| -30% | -$1.29K | ﹤0.01% | 836 |
|
2020
Q3 | $6K | Buy |
10
+3
| +43% | +$1.8K | ﹤0.01% | 637 |
|
2020
Q2 | $4K | Hold |
7
| – | – | ﹤0.01% | 743 |
|
2020
Q1 | $3.42K | Sell |
7
-10
| -59% | -$4.88K | ﹤0.01% | 696 |
|
2019
Q4 | $6.38K | Sell |
17
-6
| -26% | -$2.25K | ﹤0.01% | 859 |
|
2019
Q3 | $6.38K | Buy |
+23
| New | +$6.38K | ﹤0.01% | 938 |
|